Edit |   |
---|---|
Antigenic Specificity | CFD, Human (Lampalizumab biosimilar) |
Clone | Lampalizumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | Fab-G1 kappa |
Format | Fab fragment |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IP, FCM, FuncS, Neut, IF, Stim |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CFD Recombinant Antibody. Lampalizumab (INN) is an antigen-binding fragment of a humanized monoclonal antibody that binds to complement factor D, it was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration. |
Immunogen | n/a |
Other Names | Anti-CFD Recombinant Antibody, Research Grade Lampalizumab, Anti-Human CFD Recombinant Antibody, AFD, Anti-fD, Anti-FACTOR D, Antibody Drug Analogues, Monoclonal Antibody, YR1282, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1278466-20-8 |
Catalog # | YR1282 |
Price | please inquire |
Order / More Info | CFD, Human (Lampalizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |